MyFinsight
Home
Blog
About
Marketable securities
$264,568K
(204.71%↑ Y/Y)
Cash and cash
equivalents
$54,302K
(-53.61%↓ Y/Y)
Prepaid expenses
$4,263K
(141.39%↑ Y/Y)
Other current assets
$2,572K
(63.09%↑ Y/Y)
Total current assets
$325,705K
(57.17%↑ Y/Y)
Other non-current
assets
$3,935K
(5686.76%↑ Y/Y)
Operating lease
right-of-use assets
$542K
(-32.59%↓ Y/Y)
Property, equipment and
leasehold improvements,...
$336K
(40.59%↑ Y/Y)
Total assets
$330,518K
(58.64%↑ Y/Y)
Total liabilities and
stockholders equity
$330,518K
(58.64%↑ Y/Y)
Total stockholders
equity
$321,506K
(61.97%↑ Y/Y)
Total liabilities
$9,012K
(-8.47%↓ Y/Y)
Accumulated deficit
-$360,793K
(-16.50%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$425K
(-1870.83%↓ Y/Y)
Additional paid-in capital
$682,582K
(34.36%↑ Y/Y)
Total current
liabilities
$8,736K
(-5.46%↓ Y/Y)
Operating lease
liabilities
$276K
(-54.38%↓ Y/Y)
Common stock 0.001 par
value 400,000,000 and...
$142K
(16.39%↑ Y/Y)
Accrued expenses
$5,309K
(-11.24%↓ Y/Y)
Accounts payable
$3,098K
(4.17%↑ Y/Y)
Operating lease
liabilities
$329K
(15.03%↑ Y/Y)
Back
Back
Balance Sheet
Trevi Therapeutics, Inc. (TRVI)
Trevi Therapeutics, Inc. (TRVI)
source: myfinsight.com